Fingerprint
Dive into the research topics of 'TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer
Karen-Lise Garm Spindler, Ib Jarle Christensen, Hans Jørgen Nielsen, Anders Jakobsen, Nils Brünner